Es gab 50 kürzliche Insider-Transaktionen für Atai Beckley N.V (ATAI), darunter 27 Käufe und 16 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $59.41M und die gesamten Insider-Verkäufe auf $15.2M.
Bedeutende Insider mit kürzlicher Aktivität umfassen Feilding-mellen Cosmo, Hershberg Robert, Braunstein Scott. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — ATAI
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2025-11-25 |
Feilding-mellen Cosmo |
Director |
Aktienrückgabe |
40,400 |
$4.48 |
$180.99K |
- |
| 2025-11-05 |
Hershberg Robert |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2025-11-05 |
Hershberg Robert |
Director |
RSU-Zuteilung |
62,394 |
$1.35 |
$84.23K |
62,394 |
| 2025-11-05 |
Feilding-mellen Cosmo |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2025-11-05 |
Feilding-mellen Cosmo |
Director |
RSU-Zuteilung |
40,400 |
$4.48 |
$180.99K |
40,400 |
| 2025-11-04 |
Braunstein Scott |
Director |
RSU-Zuteilung |
56,818 |
$5.28 |
$300K |
56,818 |
| 2025-10-01 |
Barrett Christopher Ryan Cave |
See Remarks |
Unbekannt |
71,620 |
$2.86 |
$204.83K |
- |
| 2025-10-01 |
Barrett Christopher Ryan Cave |
See Remarks |
RSU-Zuteilung |
175,000 |
$5.20 |
$910K |
175,000 |
| 2025-09-30 |
Apeiron Investment Group Ltd. |
10 Percent Owner |
Umwandlung (Verkauf) |
147,950 |
- |
- |
- |
| 2025-08-14 |
Apeiron Investment Group Ltd. |
10 Percent Owner |
Informierter Kauf |
8,675,799 |
$2.19 |
$19M |
51,045,214 |
| 2025-08-13 |
Rao Srinivas |
See Remarks |
RSU-Zuteilung |
217,777 |
$2.50 |
$544.44K |
217,777 |
| 2025-06-26 |
Johnson Sabrina Martucci |
Director |
RSU-Zuteilung |
103,000 |
$2.25 |
$231.75K |
103,000 |
| 2025-06-26 |
Fischer Laurent |
Director |
RSU-Zuteilung |
103,000 |
$2.25 |
$231.75K |
103,000 |
| 2025-06-26 |
Kalali Amir H |
Director |
RSU-Zuteilung |
103,000 |
$2.25 |
$231.75K |
103,000 |
| 2025-06-26 |
Braunstein Scott |
Director |
RSU-Zuteilung |
103,000 |
$2.25 |
$231.75K |
103,000 |
| 2025-06-26 |
Smiley Andrea Heslin |
Director |
RSU-Zuteilung |
103,000 |
$2.25 |
$231.75K |
103,000 |
| 2025-06-26 |
Angermayer Christian |
10 Percent Owner |
RSU-Zuteilung |
103,000 |
$2.25 |
$231.75K |
103,000 |
| 2025-06-26 |
Hoffman John Francis |
Director |
RSU-Zuteilung |
206,000 |
$2.25 |
$463.5K |
206,000 |
| 2025-06-02 |
Angermayer Christian |
10 Percent Owner |
RSU-Zuteilung |
131,698 |
$2.49 |
$327.93K |
131,698 |
| 2025-05-15 |
Hoffman John Francis |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2025-03-24 |
Apeiron Investment Group Ltd. |
10 Percent Owner |
Informierter Kauf |
1,800,000 |
$1.40 |
$2.52M |
42,369,415 |
| 2025-03-21 |
Rao Srinivas |
See Remarks |
Informierter Verkauf |
75,418 |
$1.35 |
$101.81K |
212,942 |
| 2025-03-21 |
Kirpekar Sahil |
Chief Business Officer |
Informierter Verkauf |
48,563 |
$1.35 |
$65.56K |
115,636 |
| 2025-03-21 |
Johnson Anne Nagengast |
Chief Financial Officer |
Informierter Verkauf |
33,545 |
$1.35 |
$45.29K |
140,045 |
| 2025-03-21 |
Short Glenn Frank |
Chief Scientific Officer |
Informierter Verkauf |
13,161 |
$1.35 |
$17.77K |
42,333 |
| 2025-03-21 |
Craig Kevin James |
Chief Medical Officer |
Informierter Verkauf |
11,563 |
$1.35 |
$15.61K |
8,437 |
| 2025-03-14 |
Rao Srinivas |
See Remarks |
Optionsausübung (Verkauf) |
175,000 |
- |
- |
- |
| 2025-03-14 |
Kirpekar Sahil |
Chief Business Officer |
Optionsausübung (Verkauf) |
100,000 |
- |
- |
- |
| 2025-03-14 |
Johnson Anne Nagengast |
Chief Financial Officer |
Optionsausübung (Verkauf) |
100,000 |
- |
- |
- |
| 2025-03-14 |
Short Glenn Frank |
Chief Scientific Officer |
Optionsausübung (Verkauf) |
32,500 |
- |
- |
- |
| 2025-03-14 |
Craig Kevin James |
Chief Medical Officer |
Optionsausübung (Verkauf) |
20,000 |
- |
- |
- |
| 2025-03-03 |
Johnson Anne Nagengast |
Chief Financial Officer |
RSU-Zuteilung |
757,915 |
$1.50 |
$1.14M |
757,915 |
| 2025-03-03 |
Short Glenn Frank |
Chief Scientific Officer |
RSU-Zuteilung |
757,915 |
$1.50 |
$1.14M |
757,915 |
| 2025-03-03 |
Craig Kevin James |
Chief Medical Officer |
RSU-Zuteilung |
757,915 |
$1.50 |
$1.14M |
757,915 |
| 2025-02-14 |
Apeiron Investment Group Ltd. |
10 Percent Owner |
Informierter Kauf |
10,835,718 |
$2.10 |
$22.76M |
40,555,215 |
| 2025-01-07 |
Rao Srinivas |
See Remarks |
RSU-Zuteilung |
2,340,000 |
$1.75 |
$4.1M |
2,340,000 |
| 2025-01-02 |
Kochendoerfer Gerd |
Chief Operating Officer |
RSU-Zuteilung |
1,450,000 |
$1.60 |
$2.32M |
1,450,000 |
| 2025-01-01 |
Short Glenn Frank |
Chief Scientific Officer |
Unbekannt |
32,500 |
- |
- |
- |
| 2025-01-01 |
Craig Kevin James |
Chief Medical Officer |
Unbekannt |
20,000 |
- |
- |
- |
| 2024-12-03 |
Kochendoerfer Gerd |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2024-10-04 |
Angermayer Christian |
10 Percent Owner |
Aktienrückgabe |
624,000 |
$5.68 |
$3.54M |
- |
| 2024-10-04 |
Brand Florian |
See Remarks |
Aktienrückgabe |
4,240,000 |
$0.37 |
$1.57M |
- |
| 2024-10-04 |
Rao Srinivas |
See Remarks |
Aktienrückgabe |
709,952 |
$11.71 |
$8.31M |
- |
| 2024-10-04 |
Johnson Anne Nagengast |
Chief Financial Officer |
Aktienrückgabe |
115,152 |
$11.71 |
$1.35M |
- |
| 2024-06-13 |
Johnson Sabrina Martucci |
Director |
RSU-Zuteilung |
103,000 |
$1.34 |
$138.02K |
103,000 |
| 2024-06-13 |
Fischer Laurent |
Director |
RSU-Zuteilung |
206,000 |
$1.34 |
$276.04K |
206,000 |
| 2024-06-13 |
Kalali Amir H |
Director |
RSU-Zuteilung |
103,000 |
$1.34 |
$138.02K |
103,000 |
| 2024-06-13 |
Braunstein Scott |
Director |
RSU-Zuteilung |
206,000 |
$1.34 |
$276.04K |
206,000 |
| 2024-06-13 |
Smiley Andrea Heslin |
Director |
RSU-Zuteilung |
103,000 |
$1.34 |
$138.02K |
103,000 |
| 2024-06-13 |
Auerbach Michael |
Director |
RSU-Zuteilung |
103,000 |
$1.34 |
$138.02K |
103,000 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
